Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Viral Gastroenteritis Market from 2024 to 2025?

In recent times, the market size of viral gastroenteritis has been witnessing stable growth. The industry, which stood at $6.75 billion in 2024, is expected to rise to $7.08 billion in 2025, showcasing a compound annual growth rate (CAGR) of 5.0%. This past growth trend can be traced back to factors like the increasing occurrences of viral infections, worldwide hygiene practices, advancements in diagnostic methods, international travel and tourism, and diverse climate and environmental elements.

What Is the Projected Market Size of the Viral Gastroenteritis Market?

The market for viral gastroenteritis is predicted to experience considerable expansion in the coming years. The market is predicted to reach a value of $8.73 billion in 2029, representing a compound annual growth rate (CAGR) of 5.4%. The growth expected during the forecast period can be credited to global health readiness, the effects of climate change, a unified health approach, epidemiological monitoring systems, education and public awareness. Key trends expected during this period include the development of vaccines, progressive diagnostic techniques, the use of telemedicine in diagnosis, joint research efforts, custom-tailored medicine approaches, and the adoption of digital health solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

Who are the Major Competitors in the Viral Gastroenteritis Market Outlook?

Major companies operating in the viral gastroenteritis market include Pfizer Inc., Abbvie Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy’s Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited

What Is Fueling Growth in the Viral Gastroenteritis Market?

The rise in gastrointestinal disorders is anticipated to fuel the expansion of the viral gastroenteritis market in the upcoming years. Gastrointestinal disorders entail any disease that affects any part of the gastrointestinal tract. Treatments and medications for viral gastroenteritis offer relief to patients suffering from this condition. To illustrate, the Impact of IBD Report 2023 issued by the IBD Clinical and Research Centre, a Canadian organization focused on enhancing the quality of life for patients with Crohn’s disease and ulcerative colitis, revealed that in September 2023, the prevalence was 825 per 100,000, with over 320,000 Canadians living with inflammatory bowel disease (IBD). Given the anticipated annual increase in prevalence by 2.44%, it is projected that by 2035, 1.1% of the population, approximately 470,000 Canadians, will be dealing with IBD. Hence, this escalating prevalence of gastrointestinal disorders is a key driver propelling the growth of the viral gastroenteritis market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12127&type=smp

Which Viral Gastroenteritis Market Segments Are Growing the Fastest?

The viral gastroenteritis market covered in this report is segmented –

1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs

2) By Diagnosis: Physical Examination, Rapid Stool Test

3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

Subsegments:

1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins

2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate

3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

4) By Antimotility Agents: Loperamide, Diphenoxylate

5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

Which Industry Trends Are Shaping the Future of the Viral Gastroenteritis Market?

The viral gastroenteritis market is seeing a significant trend towards product innovation. Major players in this market are keen to develop new products to solidify their market presence. An example of this came in November 2022, when GlaxoSmithKline PLC, a leading biopharmaceutical firm based in the UK, secured approval from the US Food and Drug Administration (FDA) for its ROTARIX liquid formulation, intended to prevent rotavirus gastroenteritis in infants without the need for vaccine dose reconstitution at the point of care. Healthcare providers find this new formulation more convenient. This approval has been validated by international clinical trial data, which has shown its safety, tolerability, and equivalent immunogenicity compared to the previous lyophilized formulation.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

Which Countries Are Leading the Viral Gastroenteritis Market?

North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12127

This Report Delivers Insight On:

1. How big is the viral gastroenteritis market, and how is it changing globally?

2. Who are the major companies in the viral gastroenteritis market, and how are they performing?

3. What are the key opportunities and risks in the viral gastroenteritis market right now?

4. Which products or customer segments are growing the most in the viral gastroenteritis market?

5. What factors are helping or slowing down the growth of the viral gastroenteritis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model